Form D — Cytex Therapeutics, Inc.
0001943908-25-000001 · filed Jan 10, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06c
- Total offering
- $2,000,000
- Total sold
- $125,000
- Minimum investment
- $10,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cytex Therapeutics, Inc.
- CIK
- 1943908
- Entity
- Corporation
- Jurisdiction
- DE
- Year incorporated
- 2006
- Address
- 2609 N. DUKE STREET, SUITE 303A
DURHAM, NC 27704 - Phone
- —
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
BRADLEY T ESTES · Executive OfficerDurham, NC Find on LinkedIn ↗
-
FARSHID GUILAK · Executive OfficerDurham, NC Find on LinkedIn ↗
-
DAVID NOLAN · DirectorBONITA SPRINGS, FL Find on LinkedIn ↗
-
FRANKLIN T MOUTOS · Executive OfficerDurham, NC Find on LinkedIn ↗
-
CHRISTINE ESTES · Executive OfficerDurham, NC Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗